Ovarian Cancer Clinical Trial

Clinical Trial Finder Ovarian Cancer Trials

Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

See Locations Near You

Summary

RATIONALE: Gathering information about changes in serotonin levels in patients undergoing chemotherapy for ovarian cancer, fallopian tube cancer, or primary peritoneal cancer may help doctors learn more about constipation caused by chemotherapy.

PURPOSE: This clinical trial is studying how blood levels of serotonin effect constipation caused by chemotherapy in patients with newly diagnosed ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

View Full Description

Full Description

OBJECTIVES:

To determine if there are any alterations in serotonin levels in patients undergoing chemotherapy for ovarian, fallopian tube, or primary peritoneal cancer and if this is associated with increased constipation.

OUTLINE: Patients undergo blood sample collection prior to beginning of planned postoperative chemotherapy, after 3 and 6 courses of chemotherapy, and at the 3-month surveillance visit. Patients also complete a bowel function questionnaire at these time points.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Newly diagnosed ovarian, fallopian tube, or primary peritoneal cancer
Planned to undergo 6 courses of a taxane and platinum-containing regimen

Exclusion Criteria:

Ovarian low malignant potential tumor
History of constipation or irritable bowel syndrome
History of colorectal cancer
Prior bowel resection at time of staging/cytoreductive surgery
Prior abdominal-pelvic radiation
Prior bowel surgery

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

13

Study ID:

NCT00536523

Recruitment Status:

Terminated

Sponsor:

University of Minnesota

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Masonic Cancer Center at University of Minnesota
Minneapolis Minnesota, 55455, United States

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

13

Study ID:

NCT00536523

Recruitment Status:

Terminated

Sponsor:


University of Minnesota

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
Promising Immunotherapy Trials for Ovarian Cancer
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider